Short Interest in Lyell Immunopharma, Inc. (NASDAQ:LYEL) Expands By 71.6%
MarketBeat
Lyell Immunopharma, Inc. (NASDAQ:LYEL - Get Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 9,710,000 shares, a growth of 71.6% from the April 30th total of 5,660,000 shares. Approximately 8.1% of the company's stock are short sold. Based on an average daily trading volume, of 770,900 shares, the short-interest ratio is currently 12.6 days.
NASDAQ:LYEL